Introduction {#Sec1}
============

*Chlamydia trachomatis* (chlamydia) is the most commonly diagnosed bacterial sexually transmitted infection (STI) in England with 202,546 diagnoses in 2016, 63% of which were among 15 to 24-year-olds \[[@CR1]\]. Chlamydia is often asymptomatic; therefore, testing and treatment are essential to prevent transmission and potential negative reproductive health outcomes \[[@CR2]\]. Chlamydia can be tested for using a genital or vulvo-vaginal swab (self-administered or health care professional-administered) or a urine sample. Laboratory diagnosis is conducted using nucleic acid amplification tests (NAATs) which allow the use of non-invasive samples (i.e., urine and self-taken vulvo-vaginal swabs). General practice presents an ideal setting for testing. Over 60% of young people visit general practice annually \[[@CR3], [@CR4]\] and report a preference to receive testing and results from a general practitioner (GP) \[[@CR5]--[@CR8]\]. Positivity is higher in general practice than non-healthcare settings such as universities \[[@CR9], [@CR10]\], while regular screening is facilitated by attendance for other reasons \[[@CR9]\].

England's National Chlamydia Screening Programme (NCSP) advocates opportunistic testing (i.e., testing regardless of reason for attendance such as those who present with other ailments such as the common cold) across a range of settings (including general practice). The NCSP also recommends testing for sexually active young people annually and on change of sex partner. In 2016, approximately 25% of 15--24-year-olds in England were tested for chlamydia but only 19% of tests were conducted in general practice \[[@CR11]\]. A narrative review reported commonly cited barriers to testing in general practice (from the perspectives of both primary care practitioners \[PCP\] and young people) which include stigma, poor knowledge/training, and time constraints \[[@CR12]\]. This review, however, was conducted in 2013, and several new studies in this area have been published since. Furthermore, facilitators to testing are not well investigated, and interventions to increase testing in general practice have been disappointing \[[@CR13]--[@CR17]\]. One conceivable explanation for these disappointing results is the lack of input from theories of behaviour.

Implementing changes in general practice requires behaviour change in several agents (e.g., PCP, patients, commissioners) \[[@CR18]\] underpinned by a theoretical understanding of the behaviour \[[@CR19], [@CR20]\]. The Capability, Opportunity, Motivation, Behaviour (COM-B) model is one theory of behaviour which can contribute insights into chlamydia testing behaviour \[[@CR20]\]. COM-B posits behaviour as the result of an *interaction* between three components: capability, opportunity, and motivation (see Fig. [1](#Fig1){ref-type="fig"}). Capability can be psychological (knowledge) or physical (skills); opportunity can be social (societal influences) or physical (environmental resources); motivation can be automatic (emotion) or reflective (beliefs, intentions).Fig. 1The COM-B Model \[[@CR15]\]

The benefit of employing the COM-B Model over a single theory of behaviour is that several distinct explanatory components are outlined; thus, additional potential influences on behaviour can be considered. COM-B lies at the centre of the Behaviour Change Wheel (BCW), a tool kit for designing behaviour change interventions \[[@CR20]\]), and is the starting point of intervention development. COM-B components can be mapped onto the BCW and the Behaviour Change Technique Taxonomy which facilitates the selection of intervention strategies that are likely to be appropriate and effective in addressing the barriers and facilitators for each component. This model has been effectively applied to many health behaviours at both individual and organisational levels \[[@CR21]--[@CR28]\], but not yet to chlamydia testing.

It remains unclear how to meaningfully translate our understanding of barriers and facilitators to testing into clinical practice. While the COM-B model has primarily been applied to intervention design, its associated Theoretical Domains Framework (division of COM-B components into 14 theoretical domains \[[@CR18]\]) has recently been applied as a synthesis framework for systematic reviews in other contexts \[[@CR29]--[@CR31]\]. Hence, the COM-B model could also provide a helpful framework for evidence synthesis in a systematic review.

The application of COM-B to factors associated with the implementation of chlamydia testing in general practice will enable us to develop a coherent framework for understanding chlamydia testing, focussed on identifying appropriate behaviour change techniques to improve implementation and increase chlamydia testing \[[@CR32]\]. The aim of this systematic review was to (1) identify barriers and facilitators to chlamydia testing for young people in general practice and (2) map these onto the COM-B model.

Methods {#Sec2}
=======

The protocol, published elsewhere \[[@CR33]\], is summarised briefly here. This review was conducted according to PRISMA guidelines \[[@CR34]\] (see Additional file [1](#MOESM1){ref-type="media"}) and registered with the International Prospective Register of Systematic Reviews (CRD42016041786).

Eligibility criteria {#Sec3}
--------------------

Eligible studies had to explore facilitators and/or barriers to chlamydia testing, views towards testing, and/or acceptability of testing in general practice. A barrier was defined as a factor that obstructs or prevents chlamydia testing; a facilitator was defined as a factor that supports or promotes testing. Table [1](#Tab1){ref-type="table"} summarises the inclusion and exclusion criteria.Table 1List of inclusion/exclusion criteriaInclusion criteriaExclusion criteriaPopulation: young people (aged 15--24 years) and primary care providers (PCP; general practitioners, practice nurses, nurse practitioners)Population: exclusively on commercial sex workers, incarcerated people, people living with HIV, victims of sexual or domestic abuse or violence, intravenous drug users, and individuals with no fixed addressRandomised and non-randomised controlled trials, pre- and post-test designs, non-experiment observational (cross-sectional, case-series, case studies), qualitative (interviews, focus groups), and mixed method paperCommentary or opinion publications that did not present new dataConducted in countries where the model of delivering healthcare in general practice is comparable to the UK (Australia, Denmark, Ireland, Netherlands, and New Zealand) where (1) the GP acts as a gatekeeper to access specialist services and (2) general practice services are publicly financedConducted in countries where the healthcare system and general practice setting is not comparable to that of the UK (i.e., USA, Canada) because (1) the role of the GP in these countries differs and specialist services are readily accessible without initial GP contact and (2) most healthcare is delivered privately meaning many have to pay out-of-pocket for insurance and care. Consequently, these different systems will have distinct characteristics and influential barriers and facilitators beyond the scope of this reviewOpportunistic and systematic testing in general practiceExclusively set outside of general practice, exclusively focused on partner notification, campaigns exclusively focused on health promotion, and testing for diagnostic purposes when symptoms are present

Search strategy {#Sec4}
---------------

Seven databases (MEDLINE, PubMed, Embase, Informit, Web of Science, PsycINFO, Scopus) were searched from January 2000 to April 2018. Pre-2000 studies excluded as NAATs were introduced around this time, thus widening testing to non-clinical settings. The search strategy is presented Additional file [2](#MOESM2){ref-type="media"}. Three sets of search terms were developed relating to the context (general practice), intervention (chlamydia testing), and outcomes (barriers, facilitators) \[[@CR33]\]. Figure [2](#Fig2){ref-type="fig"} illustrates the selection process.Fig. 2Flowchart illustrating the process of inclusion and exclusion of papers in the study

Data extraction {#Sec5}
---------------

A standardised framework was devised and used to record the aims, methodological characteristics (e.g., design, data collection, participants), theoretical framework employed (if any), main findings (i.e., participant quotations, themes identified by article authors, and survey results), and conclusion of each study. Data extraction was undertaken by one reviewer (LMD) and checked by a second reviewer (HB/TH).

Quality assessment {#Sec6}
------------------

The quality of each paper was independently assessed using the Critical Appraisal Skills Programme (CASP \[[@CR35]\]) by two reviewers (LMD and HB/TH). As per recommendations for use, the tools were not used to score individual studies as such but used as a broad guide to provide a context in which to interpret findings. Because the aim was to describe and synthesise the literature, this process was not used to exclude papers.

Data synthesis and analysis {#Sec7}
---------------------------

Study characteristics and outcomes were summarised in an evidence table. First, thematic analysis \[[@CR36]\] was used to identify prominent themes. Themes were refined through discussion and the use of constant comparison within and between codes to ensure that they accurately reflected the material.

Second, the identified themes were classified into the six sub-components of the COM-B model described above (Fig. [1](#Fig1){ref-type="fig"}). Data classification, following expert guidelines \[[@CR20]\], was conducted by one reviewer (LMD) in consultation with members of the review team at multiple data-synthesis meetings (JS, JC, GR). Discrepancies were resolved by consensus.

Results {#Sec8}
=======

Thirty-nine papers met the inclusion criteria; 14 focused on patients \[[@CR37]--[@CR50]\] (Table [2](#Tab2){ref-type="table"}) and 25 on providers \[[@CR51]--[@CR75]\] (Table [3](#Tab3){ref-type="table"}). Barriers (Fig. [3](#Fig3){ref-type="fig"}) and facilitators (Fig. [4](#Fig4){ref-type="fig"}) were identified at patient, provider, and service level (i.e., factors stemming from the broader healthcare system), with some factors spanning all three levels. Most studies did not use any theory, only seven studies used any behavioural theory; six used the Theory of Planned Behaviour \[[@CR41], [@CR48], [@CR50], [@CR66], [@CR73], [@CR75]\] and one used Normalisation Process Theory \[[@CR70]\]. Some studies were qualitative evaluations of trials that had used theory for intervention development \[[@CR48], [@CR70], [@CR75]\], others used theory to guide interview questions and questionnaires \[[@CR41], [@CR66], [@CR73]\] or provide a framework for results \[[@CR50], [@CR70]\]. When judged against the CASP criteria, the majority of studies were methodologically sound, except three \[[@CR44], [@CR46], [@CR71]\] which lacked detail on several areas (e.g., recruitment strategies, rigour of data analysis). The full quality assessment is available upon request. Table [4](#Tab4){ref-type="table"} provides an overview of all results. The detailed findings of included studies are provided in Additional files [3](#MOESM3){ref-type="media"} (providers) and [4](#MOESM4){ref-type="media"} (young people), with illustrative quotes for each theme presented in Additional file [5](#MOESM5){ref-type="media"}.Table 2Characteristics of included studies with primary care professionals (PCP)AuthorLocationParticipantsDesignTheoryMethodAnalysisAllison et al. \[[@CR74]\]UK (England)26 general practice staff (9 GPs; 13 PNs; 3 practice managers; 1 receptionist) who had participated in an intervention (m = 5; f = 23)QualitativeNoneSemi-structured interviewsModified framework analysisBilardi et al. \[[@CR51]\]Australia43 GPs; intervention group *n* = 20 (m = 9; f = 11); control group *n* = 23 (m = 11; f = 12); age range = \< 35--55+ yearsQuantitativeNoneQuestionnaire following pilot cluster RCTDescriptive (percentages) and mixed-effects logistic regressionBilardi et al. \[[@CR52]\]Australia14 GPs (m = 6; f = 8)\
Age: 31--40 years = 4; 41--50 years = 4; 51--60 years = 6QuantitativeNoneQuestionnaire following pilot RCT; interviewer-administered, open endedTest for equality in proportion and thematic analysisCalamai et al. \[[@CR53]\]UK55 GPs and PNs (m = 13; f = 42)QuantitativeNoneQuestionnaireDescriptives: frequenciesFreeman et al. \[[@CR54]\]UK (England)156 healthcare staff from 25 practices (72 GPs; 46 PNs; 8 practice managers; 23 administrators and receptionists; others)QualitativeNoneFocus groupsStepwise framework analytical approach (inductive)Hocking et al. \[[@CR55]\]AustraliaGPs (*n* = 21 interview; *n* = 225 questionnaires); mean age = 49.8 yearsMixed: qualitative and quantitativeNoneSemi-structured interviews and postal questionnaireThematic analysis and descriptive statisticsKhan et al. \[[@CR56]\]Australia409 GPs (m = 233; f = 176)QuantitativeNoneQuestionnaire (paper, postal)Correlation analysis, logistic regressionLorch et al. \[[@CR60]\]Australia556 GPs (m = 338; f = 218) and 118 PNs (m = 2; f = 116) from 143 clinics; age range = 30--59 yearsQuantitativeNoneQuestionnaire (paper)Descriptives, regressionLorch et al. \[[@CR57]\]Australia72 PNs (m = 1; f = 71)QuantitativeNoneQuestionnaireChi-squared paired *t* testLorch et al. \[[@CR58]\]Australia44 GPs (m = 27; f = 16)QualitativeNoneSemi-structured interviewsThematically using content analysisLorch et al. \[[@CR59]\]Australia23 PNs (m = 1; f = 22); age range = 30--59 yearsQualitativeNoneSemi-structured interviewsThematically using content analysisLorimer et al. \[[@CR61]\]UK (Scotland)18 GPs and 8 PNsQualitativeNoneSemi-structured interviews (telephone)Framework analysis with thematic codingMa and Clarke \[[@CR62]\]UK (England)4 consultants in sexual and reproductive health, 1 consultant in public health, 1 chlamydia screening coordinator, 3 GPs and 3 PNsQualitativeNoneSemi-structured interviewsVariation of thematic analysisMcKernon and Azariah \[[@CR63]\]New Zealand76 staff participating in pilot trial: 5 receptionists, 5 clinical assistants, 24 nurses, 31 doctors, 10 practice managers (who were also doctors), and 4 operations managersQuantitativeNoneQuestionnaireDescriptivesMcNulty et al. \[[@CR64]\]UK (England)12 focus groups of GPs, PNs, practice managers, midwives, and district nurses (total *n* not reported)QualitativeNoneFocus groupsModified grounded theory approach utilising the constant comparative methodMcNulty et al. \[[@CR65]\]UK (England)General practice staff (GPs, PNs) from high/low testing rates and rural/urban areas (total *n* not reported)QualitativeNoneFocus groupsThematic analysis using constant comparative methodMcNulty et al. \[[@CR66]\]UK (England)Focus groups: 72 GPs, 46 PNs, 23 receptionists and administrators, 8 practice managers, 7 other staff.\
Interviews: 5 GPs, 3 nurses, 1 receptionist, 2health care assistants, 1 manager.QualitativeTheory of Planned BehaviourSemi-structured interviews (12) and focus groups (25)Stepwise framework analytical approachMcNulty et al. \[[@CR67]\]UK (England)9 chlamydia screening co-ordinators from areas with significant screening in general practiceQualitativeNoneSemi-structured interviews (telephone)Interpretative phenomenological thematic approachMcNulty et al. \[[@CR75]\]UK (England), Estonia, Sweden, France45general practice staff, 18 stakeholders, 13 trainers (England 25, Estonia 15, France 23; Sweden 13)QualitativeTheory of Planned BehaviourSemi-structured interviewsThematic analysisMerritt et al. \[[@CR68]\]Australia10 GPs from 6 practicesUncontrolled before and after trialNoneMeetings every 2 month during interventionDescriptive statisticsPerkins et al. \[[@CR69]\]UK (England)13 GPs; 14 PNs; 15 practice receptionists; 11 practice managersQualitativeNoneSemi-structured interviewsOpen-coding methodRicketts et al. \[[@CR70]\]UK (England)29 general practice staff: 9 GPs; 13 PNs; 7 receptionists; from 8 high and low 7 screening intervention practicesQualitative (evaluation of intervention)Normalisation Process TheorySemi-structured interviewsThematic analysis (within a Normalisation Process Theory Framework)Robertson and Williams \[[@CR71]\]UK (Wales)PNs (7 qualitative; 33 quantitative)Mixed: qualitative and quantitativeNoneSemi-structured interviews and questionnaireDescriptive statisticsSenok et al.  \[[@CR72]\]UK (Scotland)13 GP's, PNs and administrative staffFeasibility study for a RCT and qualitativeNoneIn-depth interviewsThematic analysisWallace et al. \[[@CR73]\]UK (England)General practice staff\
12 interviews; 5 GPs; 3 PNs; 1 practice manager; 3 receptionists.\
55 questionnaires (m = 5; f = 50); 18 GPS; 26 PNs; 9 receptionists; 1 practice manager; 1 research nurseMixed: qualitative and quantitativeTheory of Planned BehaviourQuestionnaire (paper = 52; online = 3)Quantitative: frequencies, *t* tests, chi-square tests\
Qualitative: thematic analysis*f* female, *GP* general practitioner, *m* male, *PN* practice nurse, *RCT* randomised controlled trialTable 3Characteristics of included studies with young people (YP)AuthorLocationParticipantsDesignTheoryMethodAnalysisBalfe et al. \[[@CR37]\]Ireland30 YP attending health services for STI test (m = 9 \[MSM = 3\]); f = 21); age range = 18--29QualitativeNoneSemi-structured interviewsThematic analysisBalfe et al. \[[@CR38]\]Ireland35 young women; late teens to late 20sQualitativeNoneSemi-structured interviewsNot reportedBrugha et al. \[[@CR39]\]Ireland6085 YP attending 5 community healthcare settings and 1 GUM clinic, over a 2-week period (m = 2379; f = 3706); age range = 18--29QuantitativeNoneQuestionnaireDescriptive statistics: frequencies and × 2 cross-tabulations with two-tailed testsEwert et al. \[[@CR49]\]Australia28 young men who were university students, age range = 18--25 (mean age = 20.8)QualitativeNoneSemi-structured interviewsContent and thematic analysisHeritage and Jones \[[@CR40]\]UK (England)18 YP; 12 via schools, 6 via GP practice (m = 6; f = 12); age range = 16--18QualitativeNoneSemi-structured interviews (2) and focus groups (*n* = 16)Long-table approach (quotes categorised according to questions)Hogan et al. \[[@CR41]\]Ireland36 YP attending general practice (m = 9; f = 27); age range = 15--24 (mean age = 21)QualitativeTheory of Planned BehaviourSemi-structured interviewsThematic analysisJones et al. \[[@CR48]\]UK (England)30 young people (m = 9; f = 21) attending general practice; age range 16--24QualitativeTheory of Planned BehaviourSemi-structured interviewsThematic frameworkMac Phail et al. \[[@CR47]\]New Zealand956 university students (m = 272; f = 682, tg = 2); age range = 18--29QuantitativeNoneQuestionnaireDescriptive statisticsMills et al. \[[@CR42]\]UK (England)45 people registered with 27 general practices who returned postal test kits (m = 19; f = 26; positive = 25, negative = 20); age range = 16--39QualitativeNoneSemi-structured interviewsThematic analysisNormansell et al. \[[@CR50]\]UK (England)17 multi-ethnic women in further education college; age range = 16--25QualitativeMultiple: Theory of Planned Behaviour, Candidacy, StigmaSemi-structured interviewsThematic frameworkPavlin et al. \[[@CR43]\]Australia24 young women; age range = 16--25QualitativeNoneSemi-structured interviewsThematic analysisPimenta et al. \[[@CR44]\]UK (England)25 sexually active women attending healthcare settings for any reason (m = 1; f = 24); age range = 16--24QualitativeNoneSemi-structured interviewsContent analysisSanter et al. \[[@CR45]\]UK (Scotland)Women: age ≤ 20 attending for contraception/pregnancy testing; ≤ 35 attending for cervical screening (positive = 4, negative = 14, awaiting = 2); age range = 15--31QualitativeNoneSemi-structured interviewsFramework approachZakher and Kang \[[@CR46]\]Australia185 university students (m = 40; f = 145); age range = 16--25 (mean age = 21)QuantitativeNoneQuestionnaire*t* tests, ANOVA, chi-square tests*ANOVA* analysis of variance, *f* female, *GUM* genitourinary medicine, *m* male, *tg* transgender, *YP* young peopleFig. 3Barriers to chlamydia testing at system, provider, and patient levels mapped on to the subcomponents of COM-B modelFig. 4Facilitators to chlamydia testing at system, provider, and patient levels mapped on to the subcomponents of COM-B modelTable 4Overview of results: Summary of barriers and facilitators across levels (patient, provider, and service) and theoretical componentCOM-B SubcomponentPatient LevelProvider LevelService LevelBarrierSourceFacilitatorSourceBarrierSourceFacilitatorSourceBarrierSourceFacilitatorSourcePhysical capabilityLack of training and skills\[[@CR55], [@CR57], [@CR60], [@CR63], [@CR64], [@CR66], [@CR69], [@CR73]\]Skills-based training\[[@CR56], [@CR59], [@CR60], [@CR62], [@CR64], [@CR65], [@CR67], [@CR70], [@CR73]--[@CR75]\]Receptionist involvement\[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR66], [@CR67], [@CR69], [@CR70], [@CR74], [@CR75]\]Receptionist involvement\[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR66], [@CR67], [@CR69], [@CR70], [@CR74], [@CR75]\]Practice nurse involvement\[[@CR58]--[@CR60], [@CR71]\]Practice nurse involvement\[[@CR55], [@CR58], [@CR59], [@CR63], [@CR66], [@CR69], [@CR71]\]Psychological capabilityLack of patient education, knowledge, and awareness\[[@CR51], [@CR55], [@CR60], [@CR73]\]Increase knowledge, education, and awareness\[[@CR37], [@CR41], [@CR43], [@CR48], [@CR49], [@CR51], [@CR54], [@CR55], [@CR61], [@CR62], [@CR64], [@CR67], [@CR68], [@CR73]\]Lack of provider knowledge and awareness\[[@CR55], [@CR60], [@CR63]--[@CR66], [@CR71], [@CR75]\]Increasing knowledge, awareness, and education\[[@CR54]--[@CR56], [@CR59], [@CR62], [@CR64], [@CR65], [@CR67], [@CR70], [@CR73], [@CR75]\]Lack of testing guidance\[[@CR64]\]Prompts and reminders\[[@CR55], [@CR66], [@CR67], [@CR70], [@CR75]\]Forgetfulness\[[@CR41], [@CR48], [@CR75]\]Forgetfulness\[[@CR51], [@CR52], [@CR55], [@CR60], [@CR66], [@CR68], [@CR70], [@CR75]\]Lack of knowledge, education, and general awareness\[[@CR55], [@CR60], [@CR63]--[@CR66], [@CR71]\]Testing guidelines\[[@CR55], [@CR60]\]Reflective motivationBeliefs regarding perceived risk\[[@CR37], [@CR41], [@CR42], [@CR44]--[@CR46]\]Beliefs that testing is responsible, mature, and healthy\[[@CR37], [@CR38]\]Assumptions and perceptions of patients\[[@CR53]--[@CR55], [@CR61], [@CR66], [@CR69], [@CR70], [@CR74], [@CR75]\]Increase confidence\[[@CR59], [@CR62], [@CR70]\]Targets set too high\[[@CR70], [@CR74]\]Beliefs about consequences of offering\[[@CR54], [@CR66], [@CR69], [@CR70], [@CR73], [@CR74]\]Testing policy: new patients' health checks\[[@CR64]\]Automatic motivationEmbarrassment and shame\[[@CR37], [@CR40]--[@CR43], [@CR48], [@CR49], [@CR55], [@CR69], [@CR70], [@CR73]\] and \[[@CR37], [@CR38], [@CR40], [@CR42], [@CR43]\]Asymptomatic infection worries\[[@CR37], [@CR44], [@CR45]\]Difficult to discuss\[[@CR52], [@CR60]--[@CR62], [@CR64], [@CR66], [@CR68]--[@CR70], [@CR73], [@CR75]\]Testing policy: based on behaviour\[[@CR41], [@CR48]\]Reward and incentive programmes\[[@CR51], [@CR55], [@CR61], [@CR62], [@CR66]--[@CR69], [@CR74], [@CR75]\]Fear\[[@CR38], [@CR41]--[@CR43], [@CR48], [@CR50]\]Feedback on efforts\[[@CR70], [@CR74], [@CR75]\]Physical opportunityTime constraints\[[@CR40], [@CR41], [@CR48]\]PCP offering testing\[[@CR41], [@CR47]\]Time constraints\[[@CR51], [@CR52], [@CR55], [@CR57]--[@CR64], [@CR66], [@CR68]--[@CR75]\]Mode of testing\[[@CR55], [@CR62], [@CR64], [@CR73], [@CR75]\]Time constraints\[[@CR40], [@CR41], [@CR48]\] and \[[@CR51], [@CR52], [@CR55], [@CR57]--[@CR64], [@CR66], [@CR68]--[@CR75]\]Promotional materials\[[@CR54], [@CR63], [@CR70], [@CR74], [@CR75]\]Receptionist involvement\[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR66], [@CR67], [@CR69], [@CR70], [@CR74], [@CR75]\]Mode of testing\[[@CR39]--[@CR41], [@CR44], [@CR48]\]Receptionist involvement\[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR66], [@CR67], [@CR69], [@CR70], [@CR74], [@CR75]\]Reception area\[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR70]\] and \[[@CR74], [@CR75]\]Testing policy: inclusion in other consultations\[[@CR48], [@CR66], [@CR67]\]Written invitations\[[@CR61], [@CR67]\]System to record offers\[[@CR66]\]Service cost to patient\[[@CR37], [@CR39], [@CR47], [@CR60]\]Simplified laboratory systems\[[@CR59], [@CR62], [@CR66], [@CR68]\]Absence of systems to record test offers\[[@CR66], [@CR69]\]Support for partner notification\[[@CR62], [@CR64], [@CR69]\]Lack of support for partner notification\[[@CR55], [@CR60], [@CR62]--[@CR64], [@CR73]\]Social opportunityStigma\[[@CR37], [@CR38], [@CR40]--[@CR43], [@CR55], [@CR61], [@CR71]\]Normalisation\[[@CR38], [@CR41]--[@CR43], [@CR61]\]Practice social norms\[[@CR66], [@CR73]\]Normalisation\[[@CR54], [@CR61], [@CR66], [@CR67], [@CR70], [@CR74]\]Testing policy: women only\[[@CR37], [@CR38], [@CR69]\]Normalisation\[[@CR52], [@CR54], [@CR55], [@CR61], [@CR63], [@CR66], [@CR67], [@CR70]\]Provider-patient relationship\[[@CR48], [@CR55], [@CR58], [@CR59], [@CR66], [@CR74]\]Consultation social context\[[@CR45], [@CR55], [@CR56], [@CR61], [@CR64], [@CR67], [@CR70], [@CR73]\]Cultural norms\[[@CR66], [@CR73]\]Testing policy: blanket testing\[[@CR38], [@CR48]\]*COM-B* capability, opportunity, motivation, behaviour

Patient level factors {#Sec9}
---------------------

### Barriers {#Sec10}

#### Psychological capability {#FPar1}

ᅟ

*Lack of patient (and public) education, knowledge, and awareness* \[[@CR51], [@CR55], [@CR60], [@CR73]\]. This was reported as a barrier by PCPs. One study of young people \[[@CR41]\] reported lack of knowledge about chlamydia, its sequelae, and the screening process as barriers.

*Forgetfulness* \[[@CR41], [@CR48], [@CR75]\]. While young people expressed enthusiasm for self-sampling, forgetting to return samples was reported as a barrier.

#### Reflective motivation {#FPar2}

ᅟ

*Beliefs regarding perceived risk* \[[@CR37], [@CR41], [@CR42], [@CR44]--[@CR46]\]. Young people who perceived themselves to be at low or no risk were less likely to test. These beliefs originated from perceived low chlamydia prevalence \[[@CR45]\], the asymptomatic nature of chlamydia \[[@CR37], [@CR45]\], personal sexual history, and the perceived sexual history of a partner. Despite feeling positive about testing \[[@CR37]\], there was no sense of urgency, so it was easy to avoid or postpone testing.

#### Automatic motivation {#FPar3}

ᅟ

*Embarrassment* \[[@CR37], [@CR40]--[@CR43], [@CR48], [@CR49], [@CR55], [@CR69], [@CR70], [@CR73]\] and *shame* \[[@CR37], [@CR38], [@CR40], [@CR42], [@CR43]\]. The terms embarrassment and shame were used interchangeably. We considered these as distinct constructs (i.e., shame is an emotional response to something considered morally wrong whereas embarrassment does not imply wrongdoing \[[@CR76], [@CR77]\]) and tried to distinguish between these where possible. Embarrassment was cited by young people to explain their aversion to reception staff offering testing kits \[[@CR40], [@CR41]\] or having to walk through reception with a sample \[[@CR48]\], being offered a test in front of parents \[[@CR40], [@CR48], [@CR49]\], and returning self-sampling kits in case they were seen by someone they knew \[[@CR41], [@CR48], [@CR49]\]. Embarrassment at having to undress in front of a PCP was also highlighted, particularly for young women \[[@CR37]\]. Shame was associated with a positive chlamydia diagnosis \[[@CR42], [@CR43]\]. Men in one study expressed little embarrassment or shame at receiving a chlamydia diagnosis and perceived it as more of an issue for women \[[@CR42]\]. Shame and embarrassment were experienced in relation to unprotected sex and a concern that a PCP would judge this behaviour \[[@CR37], [@CR41]\]. For some young women, the need to maintain a certain identity (e.g., "good girl" as opposed to a "bad girl") was a barrier to testing \[[@CR37], [@CR38], [@CR50]\] which was threatened by fear of being viewed as promiscuous or engaging in risky behaviour by a PCP \[[@CR37]\]. Participants in one study suggested that having to provide a sexual history, particularly the number of sexual partners, was a barrier to testing \[[@CR43]\].

*Fear* \[[@CR38], [@CR41]--[@CR43], [@CR48], [@CR50]\]. Fear related to receiving a positive result \[[@CR43], [@CR50]\], having to tell previous partners \[[@CR42]\], parents finding out \[[@CR41], [@CR48]\], and being judged by others \[[@CR38], [@CR41], [@CR42], [@CR50]\]. Some participants suggested that being afraid of receiving a positive result might deter people from testing in the first place \[[@CR41]\].

#### Social opportunity {#FPar4}

ᅟ

*Stigma* \[[@CR37], [@CR38], [@CR40]--[@CR43], [@CR55], [@CR61], [@CR71]\]. The stigma of having an STI could outweigh the benefits of engaging in a healthy activity such as testing \[[@CR38]\]. Some young women had preconceived negative views of the type of woman who would test for or be infected with chlamydia. Some participants were concerned that a chlamydia diagnosis would make others see them as sexually promiscuous and "dirty" \[[@CR37], [@CR38], [@CR42], [@CR43]\]. Being observed to have STI testing was similarly stigmatising \[[@CR37], [@CR38]\]. Participants were reluctant to accept a test in public locations (e.g., reception area) or to return self-sampling kits there, in case they were seen by someone they knew \[[@CR39]--[@CR41], [@CR48]\].

### Facilitators {#Sec11}

#### Psychological capability {#FPar5}

ᅟ

*Increasing knowledge, education, and awareness* \[[@CR37], [@CR41], [@CR43], [@CR48], [@CR49], [@CR51], [@CR54], [@CR55], [@CR61], [@CR62], [@CR64], [@CR67], [@CR68], [@CR73]\]. Information on chlamydia transmission, the testing process, risks of untreated infection, and ease of treatment were enablers of testing. The fear of receiving a positive result (automatic motivation barrier) could be outweighed by information on ease of treatment \[[@CR43], [@CR45]\]. Increasing awareness could be achieved through PCP discussion with patients \[[@CR41]\], sexual health education in schools \[[@CR49]\], public awareness campaigns \[[@CR43], [@CR49], [@CR51], [@CR55], [@CR61], [@CR62], [@CR64], [@CR67], [@CR68]\], and promotional materials such as leaflets and posters \[[@CR41], [@CR54], [@CR73]\]. PCPs also believed that increasing patient awareness enable testing, thereby reducing provider physical capability barriers \[[@CR67], [@CR73]\].

#### Reflective motivation {#FPar6}

ᅟ

*Beliefs that testing is responsible, mature, and healthy* \[[@CR37], [@CR38]\]. Moral aspects of testing were raised, some saw testing as a moral practice and viewing it as the "right" or "good" (links to social opportunity), "mature" thing to do, and a responsible practice to engage in. Participants anticipated feeling guilty if they transmitted an infection so testing allowed the respondents to feel that they were protecting their own and partners' health and bodies \[[@CR37], [@CR38]\].

#### Automatic motivation {#FPar7}

ᅟ

*Asymptomatic infection worries* \[[@CR37], [@CR44], [@CR45]\]. Some young people expressed concern about the damage an asymptomatic infection could have for their reproductive health which reportedly arose from contact with health promotion materials and individuals who had attended for chlamydia testing. As indicated above under the "Psychological capability" section, informing young people of the risks of asymptomatic infection can thus facilitate chlamydia testing.

#### Physical opportunity {#FPar8}

ᅟ

*PCP offering testing* \[[@CR41], [@CR47]\]. Young people anticipated feeling uncomfortable asking for a test and would prefer it to be offered by their PCP.

*Mode of testing* \[[@CR39]--[@CR41], [@CR44], [@CR48]\]. Young people viewed self-sampling kits positively by young people as they allowed the test to be done in a more convenient and comfortable location (i.e., at home) \[[@CR39]\] with urine samples preferred to vulval-vaginal swabs \[[@CR40], [@CR44]\]. The need for a discreet location and unsuitability of the reception was again highlighted (social opportunity barrier) \[[@CR41], [@CR48]\]. To minimise forgetting to return samples (psychological capability barrier), patients should complete samples prior to leaving the practice \[[@CR75]\]---and many reported a preference for doing so \[[@CR41], [@CR48]\]. Self-sampling kits were also viewed positively by staff to reduce workload, time constraints (physical capability barrier), and for ease of use (e.g., \[[@CR55], [@CR62], [@CR64]\]).

Provider level factors {#Sec12}
----------------------

### Barriers {#Sec13}

#### Physical capability {#FPar9}

ᅟ

*Lack of training and skills* \[[@CR55], [@CR57], [@CR60], [@CR63], [@CR64], [@CR66], [@CR69], [@CR73]\]. PCPs reported a lack of appropriate training and skills needed to discuss sexual health \[[@CR64]\], take sexual history \[[@CR55]\], offer a test \[[@CR63]\], respond to a positive test and manage treatment \[[@CR55]\], and conduct partner notification \[[@CR60], [@CR69]\]. This led to reduced confidence to offer testing (reflective motivation) and discuss sexual health with patients \[[@CR55], [@CR66]\]. In one study, young people felt that GPs lack sexual health expertise and thus preferred to attend sexual health clinics \[[@CR50]\].

#### Psychological capability {#FPar10}

ᅟ

*Lack of provider knowledge and awareness* \[[@CR55], [@CR60], [@CR63]--[@CR66], [@CR71], [@CR75]\]. Lack of knowledge about the epidemiology and presentation of chlamydia \[[@CR55], [@CR65]\], benefits of testing \[[@CR64]\], at-risk populations such as young people \[[@CR60]\], how to take specimens \[[@CR64], [@CR71], [@CR75]\], and treatment options \[[@CR63]\] were described. Practitioners who were unaware of the public health importance of testing and screening programmes would be less likely to find chlamydia testing a priority \[[@CR66]\].

*Forgetfulness* \[[@CR51], [@CR52], [@CR55], [@CR60], [@CR66], [@CR68], [@CR70], [@CR75]\]. In some studies, PCPs only remembered to test when patients attended for other related health issues (e.g., contraception) or revealed high-risk behaviours \[[@CR52]\]. Other PCPs remembered at the start of a trial or screening programme but forgot over time \[[@CR51]\] and lack of a formal recall/reminder system to help staff remember was a barrier \[[@CR55]\].

#### Reflective motivation {#FPar11}

ᅟ

*Assumptions and perceptions of patients* \[[@CR53]--[@CR55], [@CR61], [@CR66], [@CR69], [@CR70], [@CR74], [@CR75]\]. PCP perceptions included believing that patients were at low risk \[[@CR53], [@CR54], [@CR62], [@CR75]\] and that chlamydia was not a high priority for patients, particularly in rural areas and areas of high deprivation \[[@CR61], [@CR64], [@CR65], [@CR70]\]. Gender-related beliefs included a perception that young men did not attend general practice often \[[@CR61], [@CR66], [@CR69], [@CR74], [@CR75]\] and that women preferred to see female general practitioners (GPs) for testing which could discourage male practitioners from offering tests \[[@CR55]\]. Some also believed that patients prefer to access sexual health services from speciality clinics, and if a patient wanted a test, they would request one \[[@CR74], [@CR75]\].

*Beliefs about consequences of offering* \[[@CR54], [@CR66], [@CR69], [@CR70], [@CR73], [@CR74]\]. Some PCPs believed offering testing could offend patients by assuming sexual activity or promiscuity. This was consistent with research with young women who felt it important for PCPs to stress that a test offer does not imply their behaviour differs from the norm (relating to social opportunity) but rather was a result of a blanket testing policy \[[@CR38], [@CR43]\].

#### Automatic motivation {#FPar12}

ᅟ

*Difficult to discuss* \[[@CR52], [@CR60]--[@CR62], [@CR64], [@CR66], [@CR68]--[@CR70], [@CR73], [@CR75]\]. Some, especially older male PCPs \[[@CR69]\], found it difficult to discuss sexual health with patients due to personal discomfort \[[@CR52], [@CR60], [@CR64], [@CR66], [@CR68], [@CR70]\]. This was particularly a concern in consultations with male patients \[[@CR61], [@CR62], [@CR68]\] and in consultations unrelated to sexual health \[[@CR64], [@CR67], [@CR68], [@CR70], [@CR73], [@CR75]\]. This may relate to perceptions that women were more accustomed to sexual health-related discussions with PCPs due to reproductive health appointments (e.g., contraception, cervical screening) \[[@CR61]\].

#### Social opportunity {#FPar13}

ᅟ

*Practice social norms* \[[@CR66], [@CR73]\]. Working in a practice where chlamydia testing or screening was not the norm \[[@CR66]\] and lack of support from colleagues \[[@CR73]\] could discourage PCPs.

*Provider-patient relationship* \[[@CR48], [@CR55], [@CR58], [@CR59], [@CR66], [@CR74]\]. Some PCPs were unwilling to introduce sexual health during new patient checks in case it affected the doctor-patient relationship. PCPs expressed concern about privacy and confidentiality \[[@CR74], [@CR75]\], particularly in rural areas where they will likely know their patients socially \[[@CR58], [@CR59]\]. They were also reluctant to raise testing if a parent was present in the consultation \[[@CR66]\] or if the patient's family was known to staff \[[@CR74]\]; which is supported by research with patients \[[@CR40]\]. Patient cultural and religious factors could also act as a barrier to testing \[[@CR48], [@CR50], [@CR55], [@CR60]\].

### Facilitators {#Sec14}

#### Physical capability {#FPar14}

ᅟ

*Skills-based training* \[[@CR56], [@CR59], [@CR60], [@CR62], [@CR64], [@CR65], [@CR67], [@CR70], [@CR73]--[@CR75]\]. PCPs were willing to conduct testing if trained \[[@CR66]\] and GPs with training in STIs were more likely to offer testing \[[@CR56], [@CR65]\]. Training and the use of scripts increased confidence (reflective motivation facilitator) \[[@CR59], [@CR62], [@CR75]\]. Training should be short but regular and mandatory \[[@CR74]\] and should focus on how to make offers without increasing consultation time \[[@CR64], [@CR70], [@CR75]\], managing testing and treatment \[[@CR60], [@CR75]\], preserving confidentiality \[[@CR73]\], and dealing with patients under 16 years of age \[[@CR73]\].

#### Psychological capability {#FPar15}

ᅟ

*Increasing knowledge, awareness, and education* \[[@CR54]--[@CR56], [@CR59], [@CR62], [@CR64], [@CR65], [@CR67], [@CR70], [@CR73], [@CR75]\]. GPs with postgraduate education in STIs were more willing to offer testing to men as well as indicating greater knowledge of the need to offer to both men and women \[[@CR56]\]. Education should focus on the nature of chlamydia infection \[[@CR64]\], benefits of testing \[[@CR73]\], who and when to test \[[@CR64]\], how to manage partners \[[@CR55], [@CR75]\], wider sexual health issues \[[@CR62]\], and stress the positive views of patients towards testing \[[@CR70]\]. Older male PCPs may need specific education due to the age gap and cultural barriers between them and the target population \[[@CR67]\]. Providing education enables PCPs to answer questions and increases self-confidence regarding testing \[[@CR59]\]. PCP awareness could be increased through campaigns with posters and leaflets \[[@CR54]\] and the introduction of national target-based reward and incentive programmes (such as the Quality and Outcomes Framework in the UK) \[[@CR62], [@CR66]\].

#### Reflective motivation {#FPar16}

ᅟ

*Increase confidence* \[[@CR59], [@CR62], [@CR70]\]. Skills-based training and increasing psychological knowledge could facilitate testing by increasing confidence in offering tests. This could also help raise self-esteem and feelings of empowerment through helping PCPs (PNs in particular) realise they can make a difference with their provision of testing \[[@CR59]\].

#### Physical opportunity {#FPar17}

ᅟ

*Mode of testing* \[[@CR55], [@CR62], [@CR64], [@CR73], [@CR75]\]. Self-taken and non-invasive sampling is more acceptable to patients \[[@CR40], [@CR44]\] and reduces workload for PCPs \[[@CR62]\], thereby facilitating testing.

#### Social opportunity {#FPar18}

ᅟ

*Consultation social context* \[[@CR45], [@CR55], [@CR56], [@CR61], [@CR64], [@CR67], [@CR70], [@CR73]\]. PCPs found it easier to raise chlamydia testing in the context of sexual and reproductive health consultations, given the reasons previously discussed. Patients reinforced the acceptability of this approach \[[@CR43], [@CR44]\].

Service level factors {#Sec15}
---------------------

### Barriers {#Sec16}

#### Physical capability {#FPar19}

ᅟ

*Practice nurse involvement* \[[@CR58]--[@CR60], [@CR71]\]. There were concerns about funding and remuneration for the expansion of PN roles, increases in workload, and time constraints within consultations \[[@CR58]\]. Some PN felt a lack of support from GPs \[[@CR58]\]. Linking to social opportunity and automatic motivation, some PN in rural areas felt that patients may have privacy concerns \[[@CR58], [@CR59]\].

#### Psychological capability {#FPar20}

ᅟ

*Lack of testing guidance* \[[@CR64]\]. Many of the barriers faced by practice staff, such as lack of knowledge and discomfort in discussing testing with patients, relate to lack of guidance, for example, clarity on when and how to test asymptomatic patients.

*Lack of knowledge, education, and general awareness* \[[@CR55], [@CR60], [@CR63]--[@CR66], [@CR71]\]. Within the practice, knowledge gaps included the epidemiology and presentation of chlamydia, evidence for advantages of testing, populations at-risk, specimen collection, and appropriate treatment.

#### Reflective motivation {#FPar21}

ᅟ

*Targets set too high* \[[@CR70], [@CR74]\]. Testing targets perceived to be unachievable can result in a practice disengaging from testing, and realistic targets need to be set, reflecting the area (e.g., rural, urban) in which a practice is located.

*Testing policy: new patients' health checks* \[[@CR64]\]. Some GPs expressed reluctance to bring up chlamydia or even sexual health during new patient health checks, as they believed it could hinder the development of the doctor-patient relationship (social opportunity) and felt patients would not want information about chlamydia on their health record.

#### Automatic motivation {#FPar22}

ᅟ

*Testing policy: based on behaviour* \[[@CR41], [@CR48]\]. Testing policies which are based on sexual behaviour had the potential to cause offence to patients, made PCPs feel uncomfortable, and were felt to evoke embarrassment and shame for the patient \[[@CR48]\].

#### Physical opportunity {#FPar23}

ᅟ

*Written invitations* \[[@CR61], [@CR67]\]. Written invitations to test had disappointing results and could reduce engagement if patients were embarrassed by receiving a letter and the risk of others seeing it. Invitations should highlight that all individuals in their age group are being offered a test (i.e., blanket testing policy) \[[@CR61]\].

*Service cost to patient* \[[@CR37], [@CR39], [@CR47], [@CR60]\]. Young people and PCP mentioned that the cost of testing for the patient was a barrier to testing.

*Absence of systems to record test offers* \[[@CR66], [@CR69]\]. A lack of systematic approaches to call and recall for testing made it difficult to audit testing offers and uptake. Implementing a policy of offering a test every time a young person attends risks offence \[[@CR69]\].

*Lack of support for partner notification* \[[@CR55], [@CR60], [@CR62]--[@CR64], [@CR73]\]. Many PCPs felt they did not have the necessary support for partner notification and expressed uncertainty about how it worked, indicating a need for skills-based training \[[@CR63], [@CR73]\].

#### Social opportunity {#FPar24}

ᅟ

*Testing policy: women only* \[[@CR37], [@CR38], [@CR69]\].Testing policies focussing exclusively on women miss the opportunity to test men and reduce men's responsibility for sexual health \[[@CR69]\]. This exacerbates stigma as it associates women with chlamydia and presumed promiscuity \[[@CR37]\].

*Cultural norms* \[[@CR66], [@CR73]\]. Cultural norms within a practice were discussed in two studies and an environment where testing is not a high priority was seen as a deterrent.

### Facilitators {#Sec17}

#### Physical capability {#FPar25}

ᅟ

*Practice nurse involvement* \[[@CR55], [@CR58], [@CR59], [@CR63], [@CR66], [@CR69], [@CR71]\]. The involvement of PNs was viewed positively by both GPs and PNs. PNs expressed willingness for increased involvement in testing and management. They are often the first PCP to see patients (particularly young people); young people feel more comfortable speaking to a PN; and, PNs have more time to spend with patients. This approach could reduce the time and workload constraints for GPs and was also viewed favourably by patients \[[@CR38], [@CR39]\]. Training and education would be required to enable this facilitator \[[@CR59]\].

#### Psychological capability {#FPar26}

ᅟ

*Prompts and reminders* \[[@CR55], [@CR66], [@CR67], [@CR70], [@CR75]\]. Computer prompts/reminders facilitate testing but rely on practices putting systems in place and recognising the risk of prompt fatigue \[[@CR66]\].

*Testing guidelines* \[[@CR55], [@CR60]\]. In one Australian study, over 90% of GPs indicated that they would be likely to increase testing if national testing guidelines were introduced and enforced \[[@CR55]\]. In some cases, increasing awareness of existing guidelines could facilitate testing \[[@CR60]\].

#### Automatic motivation {#FPar27}

ᅟ

*Reward and incentive programmes* \[[@CR51], [@CR55], [@CR61], [@CR62], [@CR66]--[@CR69], [@CR74], [@CR75]\]. Evidence on the acceptability and impact of such programmes was lacking. Some PCPs interviewed suggested that having an incentive programme would help testing become a priority \[[@CR66]\] and other PCPs indicated that they would increase testing if offered incentive payments for each test performed \[[@CR55]\]. This was consistent with a drop in testing when previously offered practice incentives were removed \[[@CR61]\]. In contrast, a small financial incentive alone did not increase chlamydia testing in another study \[[@CR51]\] while PCP elsewhere did not support financial incentives as they believed they should be providing testing as part of their clinical governance service provision without extra payment \[[@CR67]\] and questioned how incentives could be justified if the testing does not have to involve a PCP \[[@CR62]\]. The need to pair incentives reminder and feedback systems was emphasised \[[@CR51]\]. However, there remains uncertainty as to how to offer any incentive, for example, how much should it be and should it be offered to the practice or the PCP \[[@CR51]\].

*Feedback on efforts* \[[@CR70], [@CR74], [@CR75]\]. Regular feedback helped personally motivate PCPs and facilitate the embedding of chlamydia testing into general practice. Feedback should be sustained \[[@CR74]\] and focus on testing rates and the numbers of tests performed \[[@CR70], [@CR75]\].

#### Physical opportunity {#FPar28}

ᅟ

*Promotional materials* \[[@CR54], [@CR63], [@CR70], [@CR74], [@CR75]\]. Posters and leaflets in waiting rooms or handed out by reception were cited as effective tools for encouraging patients to ask for tests. In one chlamydia testing pilot programme, PCPs identified patient-targeted posters and leaflets as being vital to the pilot's success. However, it was also pointed out that promotional materials may lose their impact if left on display too long \[[@CR54]\].

*Testing policy: inclusion in other consultations* \[[@CR48], [@CR66], [@CR67]\]. Offering testing as part of other consultations (e.g., new patients' health checks, travel vaccination consultations) was considered an enabler to test new patients in the target population and those with who may rarely visit a GP \[[@CR66]\]. This approach could also help normalise testing (social opportunity).

*System to record offers*, \[[@CR66]\]. The introduction of a system which records testing offers and uptake would facilitate testing, and also prevent multiple offers, which some PCPs feared would lead to offence or irritation.

*Simplified laboratory systems* \[[@CR59], [@CR62], [@CR66], [@CR68]\]. Simplified request forms and processes for data feedback from pathology providers was supported.

*Support for partner notification* \[[@CR62], [@CR64], [@CR69]\]. Having support and pathways for partner notification may encourage more PCPs to offer testing. Some believed responsibility for partner notification should lie with sexual health clinics \[[@CR69]\], and any increase in testing should be accompanied by an increase in staffing \[[@CR64]\].

#### Social opportunity {#FPar29}

ᅟ

*Testing policy: blanket testing* \[[@CR38], [@CR48]\]. Young people felt it important for PCPs to stress that a test offer does not signify their behaviour deviates significantly from the norm (relating to social opportunity) but rather was a result of a blanket testing policy.

Cross-cutting factors {#Sec18}
---------------------

Three over-arching factors were identified which transcend patient, provider, service levels, and span multiple COM-B subcomponents.

### Barriers {#Sec19}

#### Physical opportunity {#FPar30}

ᅟ

*Time constraints*. Patients described consultations as often "rushed" and were aware of the limited time that PCPs have \[[@CR40], [@CR41], [@CR48]\]. PCPs \[[@CR51], [@CR52], [@CR55], [@CR57]--[@CR64], [@CR66], [@CR68]--[@CR75]\] reported that consultation length was insufficient to allow testing, in addition to discussing the primary consultation reason and other priority issues. Testing requires time to discuss sexual health, gain permission, and raise partner notification \[[@CR52], [@CR68]\].

### Facilitators {#Sec20}

#### Social opportunity {#FPar31}

ᅟ

*Normalisation*. Normalising chlamydia testing for patients \[[@CR38], [@CR41]--[@CR43], [@CR61]\], PCPs \[[@CR54], [@CR61], [@CR66], [@CR67], [@CR70], [@CR74]\], and at service level \[[@CR52], [@CR54], [@CR55], [@CR61], [@CR63], [@CR66], [@CR67], [@CR70]\] was raised as a way of destigmatising chlamydia infection and facilitating testing. Services in which testing was part of everyday practice (e.g., new patient checks, travel vaccinations, or young people's clinics) reported high levels of testing \[[@CR66], [@CR67]\]. Several strategies were proposed. First, framing chlamydia as a public health issue would allow more open discussion. Second, avoiding requests for the patient to provide a detailed sexual history (particularly partner numbers) when testing, which would also counteract the barrier of embarrassment. Third, blanket testing policies in which all young people are offered a test, which could also reduce automatic motivation barriers for patients (fear of judgement, embarrassment, and shame) and staff should also make this policy clear when offering tests to patients \[[@CR70], [@CR74]\] or sending reminder letters \[[@CR61]\]. Fourth, education campaigns for patients and the general public \[[@CR38], [@CR43]\]. Fifth, promotion and discussion of testing at staff practice meetings \[[@CR66]\]. Sixth, fostering a culture of shared learning by talking with staff about difficulties, team huddles prior to clinics, and regular reminders \[[@CR63]\]. A flexible approach to testing is also important; practices should adopt a testing policy that suits their patients, practice layout, staffing, and opening times \[[@CR67]\].

### Barrier/facilitator {#Sec21}

#### Physical capability and physical opportunity {#FPar32}

ᅟ

*Receptionist involvement* \[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR66], [@CR67], [@CR69], [@CR70], [@CR74], [@CR75]\]. The involvement of reception staff could facilitate testing by reducing the barrier of workload and time constraints. In one study, practices offered patients self-testing kits without a consultation to save time \[[@CR66]\]. In another study, it was estimated that testing could add 10 min to a consultation, which could be reduced to 2 or 3 min if patients were provided with the testing form and leaflet at reception \[[@CR69]\]. However, receptionists lack medical training (psychological capability) and so may be ill-equipped to answer patient questions regarding testing \[[@CR44], [@CR66], [@CR67], [@CR69], [@CR70]\]. Young people \[[@CR38], [@CR40], [@CR41], [@CR44], [@CR48], [@CR70]\] and PCP \[[@CR74], [@CR75]\] deemed the reception area to be an unacceptable location to offer information about chlamydia due to patient privacy concerns (social opportunity).

Discussion {#Sec22}
==========

This is the first systematic review to conduct a theoretical analysis of barriers and facilitators to chlamydia testing for young people and PCP in general practice. Building on previous work in this field, this review demonstrates considerable overlap between perceptions of young people and PCP on the barriers and facilitators to chlamydia testing across patient, provider, and service levels. Both groups emphasised the potential of the chlamydia testing policies (e.g., testing based on patient behaviour; women-only testing) to imply judgements about sexual behaviour and identity, particularly through women-only testing or when sexual history was asked. This had particular resonance for women who were more often offered testing in a context where staff described widespread reluctance to initiate sexual health conversations with men. Patients and staff agreed on the need to offer tests within a context that fully addressed concerns including the potential stigma of chlamydia testing. The need to normalise test offers as universal, and embed it in routines, was emphasised by both groups as key to minimising the stigma of feeling judged. Concerns about privacy were also emphasised by both groups, particularly where the reception area and staff were involved in implementing testing. This was seen as a place where young people felt exposed, particularly in small town or rural settings. Both groups experienced the allocated time for consultations as a competing pressure, and PCPs struggled to reconcile the need to discuss the relevance of testing to young people given the workload this would create, whatever the model for test offer.

While most themes could be categorised with the COM-B Model, some did not fit neatly within one subcomponent. This mirrors the hypothesised relationships between components of the model (Fig. [1](#Fig1){ref-type="fig"}); opportunity and capability can influence motivation, while behaviour can alter capability, motivation, and opportunity. For example, PCPs who lacked training (physical capability) and knowledge regarding chlamydia testing (psychological capability) were less confident in conducting tests (beliefs about capability---reflective motivation). Forgetfulness (psychological capability) related to lack of a reminder system (physical opportunity). Patient's perceived risk (reflective motivation) was mediated by psychological capability through awareness of chlamydia. Furthermore, we categorised the emotions of embarrassment and shame under automatic motivation. However, these closely link to the social opportunity component as these feelings result from the comparison of the self to social standards. The intersections across subcomponents reflect the complexity of chlamydia testing behaviour.

Limitations {#Sec23}
-----------

PCP views of what young people may feel about chlamydia testing in the general practice setting provide some clues about barriers and facilitators to implementation. However, these are expressed in a setting and over a period where chlamydia and other STI testing practices and rates remain highly variable \[[@CR78]\]. PCP comments may be offered to justify or rationalise a *status quo*, and suggested facilitators or barriers may or may not be correctly identified. Generally, studies did not report the demographic features or testing patterns of the practices in which PCP worked, which would have helped contextualise the comments of staff.

Young people participating in these studies may or may not have experienced an offer of chlamydia testing, and if they have, it may have been in any setting. While indicative, their feelings at interview may or may not represent what would actually happen if offered a test at their GP surgery, and again, the studies available do not allow us to interrogate their actual experience.

Implications for policy and practice {#Sec24}
------------------------------------

This review has built on previous literature by highlighting the complex determinants of chlamydia testing. Across all three levels, multiple barriers and facilitators were identified relating to psychological capability and physical and social opportunity. Given the nature of the studies included (mostly cross-sectional), we cannot state which component represents the most important influence on chlamydia testing. To increase testing, we should focus on targeting multiple factors, specifically (1) normalisation, (2) communication, (3) infection-specific information and education, and (4) mode of testing. Normalisation and integration into routine appears to be an influential facilitator with testing integrated into everyday practice and could be reinforced by external sources, such as national guidelines and reward and incentive programmes based on outcomes. Second, good communication in the interaction between the PCP and patient is essential. Offers need to be framed appropriately; emphasising the offer is universal while sexual history taking must be approached with caution since it may undermine testing. Third, educational and awareness interventions for young people should focus on infection-specific information (i.e., chlamydia's long-term impact on fertility and its asymptomatic nature). Finally, regarding mode of testing, small modifications (such as the use of urine testing) have the ability to simultaneously reduce multiple barriers such as time, workload, and stigma. It is clear that in order to increase chlamydia testing in primary care and reduce the transmission chain in the population, a multifaceted theory- and evidence-based approach is needed.

Conclusions {#Sec25}
===========

Unlike previous reviews, we took a multi-level theoretically informed approach to synthesise data addressing barriers and facilitators to chlamydia testing in general practice. Through the application of COM-B, a coherent framework for explaining chlamydia testing has been developed. This review is only the first step towards developing theory- and evidence-based interventions to increase chlamydia testing in general practice. Future research should identify the intervention types and behaviour change techniques which would be suitable to address the factors identified to improve implementation of chlamydia testing in general practice and reduce the transmission chain in the population.
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COM-B model

:   Capability, Opportunity, Motivation, Behaviour Model

GP

:   General practitioner

NAATs

:   Nucleic acid amplification tests

NCSP

:   National Chlamydia Screening Programme

PCP

:   Primary care professional

PN

:   Practice nurse

PRISMA

:   Preferred Reporting Items for Systematic Reviews and Meta-Analyses

RCT

:   Randomised controlled trial

STI

:   Sexually transmitted infection
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